{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:42:09Z","timestamp":1785235329109,"version":"3.55.0"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.forsciint.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T17:15:11Z","timestamp":1508519711000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Conversion factors for assessment of driving impairment after exposure to multiple benzodiazepines\/z-hypnotics or opioids"],"prefix":"10.1016","volume":"281","author":[{"given":"Maren Cecilie","family":"Strand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rg","family":"M\u00f8rland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Sl\u00f8rdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cato","family":"Innerdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond","family":"Aamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grete","family":"Mathisrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigdis","family":"Vindenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.forsciint.2017.10.022_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2011.11.004","article-title":"Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway","volume":"219","author":"Vindenes","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0010","unstructured":"Folkehelseinstituttet. Rusmiddelstatistikk Funn i blodpr\u00f8ver hos bilf\u00f8rere mistenkt for p\u00e5virket kj\u00f8ring 2015. fag Ofr; 2016."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0015","unstructured":"Samferdselsdepartementet Revidering av forskrift om faste grenser for p\u00e5virkning av andre berusende eller bed\u00f8vende middel enn alkohol m.m. Vurdering av eksisterende grenser og forslag til faste grenser for flere stoffer. 2015."},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0020","first-page":"89","article-title":"Driving under the influence of non-alcohol drugs \u2014 an update. Part I: epidemiological studies","volume":"27","author":"Gjerde","year":"2015","journal-title":"Forensic Sci. Rev."},{"issue":"8","key":"10.1016\/j.forsciint.2017.10.022_bib0025","doi-asserted-by":"crossref","first-page":"e43496","DOI":"10.1371\/journal.pone.0043496","article-title":"A case-control study estimating accident risk for alcohol, medicines and illegal drugs","volume":"7","author":"Kuypers","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0030","first-page":"105","article-title":"Driving under the influence of alcohol, illicit drugs and medicines Risk estimations from different methodological approaches","volume":"1","author":"Hargutt","year":"2011","journal-title":"DRUID"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hup.470060305","article-title":"Effects of single doses of alprazolam and alcohol alone and in combination on psychological performance","volume":"6","author":"Bond","year":"1991","journal-title":"Hum. Psychopharmacol.: Clin. Exp."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02245075","article-title":"Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance","volume":"115","author":"Chait","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004714-198608000-00002","article-title":"Effects of buspirone and diazepam, alone and in combination with alcohol, on skilled performance and evoked potentials","volume":"6","author":"Erwin","year":"1986","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2003.08.002","article-title":"The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving","volume":"72","author":"Lenne","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cpt1974154368","article-title":"Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving","volume":"15","author":"Linnoila","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.npp.1300894","article-title":"Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol","volume":"31","author":"Ramaekers","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0065","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.aap.2010.05.006","article-title":"The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks","volume":"42","author":"Ronen","year":"2010","journal-title":"Accid. Anal. Prev."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00213-011-2349-6","article-title":"Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers","volume":"218","author":"Zacny","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0085","series-title":"Rang and Dale\u2019s Pharmacology","author":"Rang","year":"2012"},{"issue":"Suppl 1","key":"10.1016\/j.forsciint.2017.10.022_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00023210-200418001-00004","article-title":"The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents","volume":"18","author":"Sanger","year":"2004","journal-title":"CNS Drugs"},{"issue":"Suppl. 5","key":"10.1016\/j.forsciint.2017.10.022_bib0095","first-page":"6","article-title":"Mechanisms of sleep induction by GABA(A) receptor agonists","volume":"68","author":"Harrison","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0100","series-title":"Rang and Dale\u2019s Pharmacology","first-page":"596","author":"Rang","year":"2007"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0105","unstructured":"C.H. Ashton, Benzodiazepine equivalence Table 2007. Available from: http:\/\/www.benzo.org.uk\/bzequiv.htm."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004714-199708000-00024","article-title":"Can you provide a table of equivalences for benzodiazepines and other marketed benzodiazepine receptor agonists?","volume":"17","author":"Shader","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2013.759209","article-title":"Understanding the pharmacokinetics of anxiolytic drugs","volume":"9","author":"Altamura","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1037\/1064-1297.3.4.432","article-title":"A review of the effects of opioids on psychomotor and cognitive functioning in humans","volume":"3","author":"Zacny","year":"1995","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0125","series-title":"Goodman & Gilman\u2019s The pharmacological basis of therapeutics","article-title":"Opioid analgesics and antagonists","author":"Reisine","year":"1996"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0130","series-title":"Guidance for the Use and Reduction of Misuse of Benzodiazepines and Other Hypnotics and Anxiolytics in General Practice","author":"Ford","year":"2014"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0135","unstructured":"Samferdselsdepartementet. Etablering av faste grenser for p\u00e5virkning av andre stoff enn alkohol. Forslag til forbudsgrenser og straffeutm\u00e5lingsgrenser for p\u00e5virkning av andre stoff enn alkohol. 2010."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02657051","article-title":"Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous-system reactivity in healthy-volunteers","volume":"39","author":"Linnoila","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0773.1973.tb01461.x","article-title":"Mental and psychomotor effects of diazepam and ethanol","volume":"32","author":"Haffner","year":"1973","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02244959","article-title":"Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines","volume":"107","author":"Ingum","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0773.1974.tb01551.x","article-title":"Combined effects of diazepam and ethanol on mental and psychomotor functions","volume":"34","author":"Morland","year":"1974","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"issue":"6\u20137","key":"10.1016\/j.forsciint.2017.10.022_bib0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s002280000167","article-title":"Driving under light and dark conditions: effects of alcohol and diazepam in young and older subjects","volume":"56","author":"Vanakoski","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0165","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0091-3057(97)00506-6","article-title":"Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory","volume":"59","author":"Mattila","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2\u20133","key":"10.1016\/j.forsciint.2017.10.022_bib0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-3057(94)00399-4","article-title":"Lorazepam and diazepam differently impair divided attention","volume":"51","author":"Jalava","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000542-198411000-00008","article-title":"Physostigmine: effectiveness as an antagonist of respiratory depression and psychomotor effects caused by morphine or diazepam","volume":"61","author":"Bourke","year":"1984","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0180","first-page":"157","article-title":"Concentration-related effects of morphine on cognition and motor control in human subjects","volume":"5","author":"Kerr","year":"1991","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0185","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/hup.470080604","article-title":"Cognitive and motor function impairments during continuous opioid analgesic infusions","volume":"8","author":"Coda","year":"1993","journal-title":"Hum. Psychopharmacol.: Clin. Exp."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0190","series-title":"The Role of the Drinking Driver in Traffic Accidents (The Grand Rapids Study)","author":"Borkenstein","year":"1964"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0195","unstructured":"H. Kr\u00fcger, Niedrige Alkoholkonzentrationen und Fahrverhalten (Low alcohol concentrations and driving performance). Bundesanstalt f\u00fcr Stra\u00dfenwesen, Unfall-und Sicherheitsforschung Stra\u00dfenverkehr. 1990 (78)."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsr.2009.07.002","article-title":"The long beach\/fort lauderdale relative risk study","volume":"40","author":"Blomberg","year":"2009","journal-title":"J. Saf. Res."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0205","series-title":"A Review of the Literature on the Effects of Low Doses of Alcohol on Driving-Related Skills","author":"Moskowitz","year":"2000"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01371332","article-title":"Low blood alcohol concentrations and driving impairment","volume":"106","author":"Ferrara","year":"1994","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0215","first-page":"763","article-title":"Effects of low alcohol dosages: a review of the literature","volume":"T92","author":"Kr\u00fcger","year":"1993","journal-title":"Alcohol Drugs Traffic Saf."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0220","first-page":"39","article-title":"Low-dose alcohol effects on human behavior and performance","volume":"11","author":"Holloway","year":"1995","journal-title":"Alcohol Drugs Driv."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1037\/h0076658","article-title":"Effects of alcohol on human performance: an integration of research findings based on an abilities classification","volume":"60","author":"Levine","year":"1975","journal-title":"J. Appl. Psychol."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0230","series-title":"Effects of Low Doses of Alcohol on Driving-Related Skills: A Review of the Evidence","author":"Moskowitz","year":"1988"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0235","article-title":"The relationship between drivers\u2019 blood alcohol concentration (BAC) and actual driving performance during high speed travel. Alcohol, drugs and traffic safety","author":"Louwerens","year":"1986","journal-title":"Proceedings of the 10th International Conference on Alcohol, Drugs and Traffic Safety"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0240","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0245","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00280132","article-title":"The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state","volume":"42","author":"Scavone","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0250","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2009"},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0255","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0893-133X(02)00310-X","article-title":"Effects of Alprazolam on driving ability memory functioning and psychomotor performance: a randomized, placebo-controlled study","volume":"27","author":"Verster","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0260","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00213-006-0669-8","article-title":"Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1mg","volume":"191","author":"Leufkens","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01271440","article-title":"Biopharmaceutical and clinical pharmacokinetic profile of bromazepam","volume":"4","author":"Kaplan","year":"1976","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0270","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/clpt.1987.72","article-title":"Bromazepam pharmacokinetics \u2014 influence of age, gender, oral-contraceptives, cimetidine, and propranolol","volume":"41","author":"Ochs","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1248\/bpb1978.13.269","article-title":"Effect of food on the bioavailability of bromazepam following oral administration in healthy volunteers","volume":"13","author":"Fujii","year":"1990","journal-title":"J. Pharmacobiodyn."},{"issue":"8\u20139","key":"10.1016\/j.forsciint.2017.10.022_bib0280","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-003-0681-4","article-title":"The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers","volume":"59","author":"Oda","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0773.1994.tb01371.x","article-title":"Pharmacokinetics of a single oral dose of clobazam in patients with liver disease","volume":"74","author":"Monjanel-Mouterde","year":"1994","journal-title":"Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0290","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.1981.tb01180.x","article-title":"Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients","volume":"11","author":"Tedeschi","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.forsciint.2017.10.022_bib0295","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1111\/j.1365-2125.1979.tb04665.x","article-title":"Pharmacokinetics of single and multiple doses of clobazam in humans","volume":"7","author":"Rupp","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0300","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-2125.1984.tb02558.x","article-title":"Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients","volume":"18","author":"Jawad","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF00542148","article-title":"Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage","volume":"26","author":"Ochs","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0310","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/FTD.0b013e3181b1dd76","article-title":"Pharmacokinetic\/pharmacodynamic modeling of psychomotor impairment induced by oral clonazepam in healthy volunteers","volume":"31","author":"dos Santos","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"1 Suppl","key":"10.1016\/j.forsciint.2017.10.022_bib0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269881193007001051","article-title":"Comparison of the relationship between structure and CNS effects for lorazepam, clonazepam and alprazolam","volume":"7","author":"Ellinwood","year":"1993","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.forsciint.2017.10.022_bib0320","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00228-005-0032-8","article-title":"Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity","volume":"61","author":"Fukasawa","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0325","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00228-004-0789-1","article-title":"Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism","volume":"60","author":"Araki","year":"2004","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0330","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00228-005-0904-y","article-title":"Induction of the metabolism of etizolam by carbamazepine in humans","volume":"61","author":"Kondo","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0335","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00280074","article-title":"Single and multiple dose pharmacokinetics of etizolam in healthy-subjects","volume":"40","author":"Fracasso","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0340","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","article-title":"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users","volume":"27","author":"Abanades","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0345","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1986.tb08985.x","article-title":"Hypnotics and actual driving performance","volume":"332","author":"O\u2019Hanlon","year":"1986","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"10","key":"10.1016\/j.forsciint.2017.10.022_bib0350","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/j.1552-4604.1981.tb01745.x","article-title":"Effects of alcohol and flunitrazepam on mood and performance in healthy young men","volume":"21","author":"Linnoila","year":"1981","journal-title":"J. Clin. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.forsciint.2017.10.022_bib0355","first-page":"127","article-title":"Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam","volume":"17","author":"Seppala","year":"1982","journal-title":"Int. Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0360","first-page":"47","article-title":"Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep-deprivation and placeboe","volume":"21","author":"Vermeeren","year":"1995","journal-title":"Acta Ther."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0365","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00427897","article-title":"Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam","volume":"86","author":"Ellinwood","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0370","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0021-9673(00)99288-4","article-title":"Determination of nitrazepam in serum by gas\u2013liquid chromatography: application in bioavailability studies","volume":"111","author":"Jensen","year":"1975","journal-title":"J. Chromatogr."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0375","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00427570","article-title":"An investigation into the interaction between ethanol at low doses and the benzodiazepines nitrazepam and temazepam on psychomotor performance in normal subjects","volume":"81","author":"Taberner","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0380","first-page":"118","article-title":"Drug interaction on psychomotor skills related to driving: hypnotics and alcohol","volume":"51","author":"Linnoila","year":"1973","journal-title":"Ann. Med. Exp. Biol. Fenn."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0385","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2125.1985.tb05078.x","article-title":"The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance","volume":"20","author":"Tedeschi","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0390","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00427892","article-title":"Kinetics and neuropsychologic effects of IV diazepam in the presence and absence of its active N-desmethyl metabolite in humans","volume":"70","author":"Elsass","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00427891","article-title":"Anxiety and sedation during a stressful situation after single dose of diazepam versus N-desmethyldiazepam\u2014a controlled trial","volume":"70","author":"Hendel","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0400","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2125.1978.tb00859.x","article-title":"Immediate and residual effects in man of the metabolites of diazepam","volume":"6","author":"Clarke","year":"1978","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0405","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00428321","article-title":"Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepate","volume":"66","author":"Greenblatt","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00421024","article-title":"Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers","volume":"43","author":"Dasberg","year":"1975","journal-title":"Psychopharmacologia"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)32259-7","article-title":"Oxazepam kinetics: effects of age and sex","volume":"215","author":"Greenblatt","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-198106020-00001","article-title":"Clinical pharmacokinetics of oxazepam and lorazepam","volume":"6","author":"Greenblatt","year":"1981","journal-title":"Clin. Pharmacokinet."},{"issue":"16","key":"10.1016\/j.forsciint.2017.10.022_bib0425","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF01721923","article-title":"Disposition of oxazepam in relation to age, sex, and cigarette smoking","volume":"59","author":"Ochs","year":"1981","journal-title":"Klin. Wochenschr."},{"issue":"Suppl. 1 (1)","key":"10.1016\/j.forsciint.2017.10.022_bib0430","first-page":"40","article-title":"Pharmacokinetics of oxazepam in healthy volunteers","volume":"40","author":"Alvan","year":"1977","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0435","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hup.470070502","article-title":"A comparative-study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 Mg and oxazepam 50 Mg","volume":"7","author":"Volkerts","year":"1992","journal-title":"Hum. Psychopharm. Clin."},{"issue":"8","key":"10.1016\/j.forsciint.2017.10.022_bib0440","first-page":"516","article-title":"Abuse of phenazepam?new phenomenon in Sweden. Benzodiazepine derivative from Russia caused severe intoxication","volume":"106","author":"Mrozkowska","year":"2009","journal-title":"Lakartidningen"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0445","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03189565","article-title":"Species differences in phenazepam kinetics and metabolism","volume":"7","author":"Zherdev","year":"1982","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0450","first-page":"66","article-title":"Correlation of the clinical pharmacological action of a single dose of fenazepam with the EEG dynamics and pharmacokinetics","volume":"49","author":"Uvarova","year":"1986","journal-title":"Farmakol. Toksikol."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0455","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00213-012-2883-x","article-title":"Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers","volume":"226","author":"Carter","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2125.1996.tb00160.x","article-title":"Triazolam pharmacokinetics and pharmacodynamics in Caucasians and Southern Asians: ethnicity and CYP3A activity","volume":"41","author":"Kinirons","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0465","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2125.1986.tb02951.x","article-title":"Population study of triazolam pharmacokinetics","volume":"22","author":"Friedman","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0470","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2125.1987.tb03112.x","article-title":"Lack of influence of cigarette-smoking on triazolam pharmacokinetics","volume":"23","author":"Ochs","year":"1987","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0475","first-page":"115","article-title":"Actions and interactions of hypnotics on human-performance \u2014 single doses of zopiclone, triazolam and alcohol","volume":"5","author":"Kuitunen","year":"1990","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0480","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2165\/00003088-199529030-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications","volume":"29","author":"Salva","year":"1995","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0485","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s002130050997","article-title":"Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans","volume":"144","author":"Rush","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.forsciint.2017.10.022_bib0490","first-page":"309","article-title":"The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function","volume":"56","author":"Wilkinson","year":"1995","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0495","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00004714-200212000-00007","article-title":"Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance","volume":"22","author":"Verster","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0500","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00003088-199529060-00004","article-title":"Clinical pharmacokinetics of zopiclone","volume":"29","author":"Fernandez","year":"1995","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.forsciint.2017.10.022_bib0505","first-page":"2124","article-title":"Zopiclone: is it a pharmacologic agent for abuse?","volume":"53","author":"Cimolai","year":"2007","journal-title":"Can. Fam. Phys."},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0510","first-page":"224","article-title":"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol","volume":"25","author":"Vermeeren","year":"2002","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0515","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/JCP.0b013e3181b57b43","article-title":"Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20mg, zopiclone 7.5mg, and placebo","volume":"29","author":"Leufkens","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0520","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/JCP.0b013e3182214be6","article-title":"Psychomotor performance after intake of zopiclone compared with intake of ethanol: a randomized, controlled, double-blinded trial","volume":"31","author":"Gustavsen","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.forsciint.2017.10.022_bib0525","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/j.1360-0443.2007.02009.x","article-title":"Developing limits for driving under cannabis","volume":"102","author":"Grotenhermen","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0530","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1520\/JFS14739J","article-title":"Beta-hydroxybutyric acid \u2014 an indicator for an alcoholic ketoacidosis as cause of death in deceased alcohol abusers","volume":"45","author":"Iten","year":"2000","journal-title":"J. Forensic Sci."},{"issue":"7","key":"10.1016\/j.forsciint.2017.10.022_bib0535","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P","article-title":"Marijuana, alcohol and actual driving performance","volume":"15","author":"Ramaekers","year":"2000","journal-title":"Hum. Psychopharm. Clin."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0540","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.aap.2009.04.021","article-title":"The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand","volume":"42","author":"Lenne","year":"2010","journal-title":"Accid. Anal. Prev."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0545","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.aap.2007.10.011","article-title":"Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol","volume":"40","author":"Ronen","year":"2008","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0550","series-title":"Marijuana and Actual Driving Performance","author":"Robbe","year":"1993"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0555","article-title":"Marijuana\u2019s effects on actual driving performance","author":"Robbe","year":"1995","journal-title":"The 13th International Conference on Alcohol, Drugs and Traffic Safety (T\u201995)"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0560","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2125.1992.tb04129.x","article-title":"Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses","volume":"34","author":"Ferrara","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0565","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/21.5.507","article-title":"Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients","volume":"21","author":"Scharf","year":"1998","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0570","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(99)00044-5","article-title":"Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes","volume":"82","author":"Schmid","year":"1999","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0575","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002130050503","article-title":"Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans","volume":"135","author":"Krystal","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0580","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0585","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cpt196455611","article-title":"Persistence of lysergic acid diethylamide in the plasma of human subjects","volume":"5","author":"Aghajanian","year":"1964","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.forsciint.2017.10.022_bib0590","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00228-007-0377-2","article-title":"Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers","volume":"63","author":"Jensen","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0595","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0022-3565(24)36921-6","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers","volume":"282","author":"Zacny","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0600","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1742-7843.2008.00250.x","article-title":"Pharmacokinetic-pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteers","volume":"103","author":"Jensen","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0605","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2125.1989.tb05393.x","article-title":"Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac","volume":"27","author":"MacDonald","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0610","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF00541294","article-title":"Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers","volume":"31","author":"Manner","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0615","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00544557","article-title":"Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers","volume":"33","author":"Saarialho-Kere","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0620","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00542102","article-title":"Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method","volume":"20","author":"Meresaar","year":"1981","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0625","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00426715","article-title":"Performance differences between addicts and non-addicts","volume":"52","author":"Rothenberg","year":"1977","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0630","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0635","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000542-200009000-00009","article-title":"Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers","volume":"93","author":"Dershwitz","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.forsciint.2017.10.022_bib0640","unstructured":"Tabell 1 Ekvianalgetiske doser av opioidanalgetika og virkningstid. Norsk legemiddelh\u00e5ndbok. 2013."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0645","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2125.1992.tb04090.x","article-title":"The pharmacokinetics and metabolism of oxycodone after intramuscular and oral-administration to healthy-subjects","volume":"33","author":"Poyhia","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0650","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/js950403a","article-title":"Differential effects of food on the bioavailability of controlled-release oxycodone tablets and immediate-release oxycodone solution","volume":"85","author":"Benziger","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0655","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1517\/17425255.2013.779669","article-title":"Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration","volume":"9","author":"Klimas","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0660","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1742-7843.2010.00582.x","article-title":"Grapefruit juice enhances the exposure to oral oxycodone","volume":"107","author":"Nieminen","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0665","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0009-9236(98)90051-0","article-title":"Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"64","author":"Heiskanen","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0670","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0091270009336444","article-title":"Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone","volume":"50","author":"Gronlund","year":"2010","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0675","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00228-010-0893-3","article-title":"Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"67","author":"Kummer","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0680","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2010.00673.x","article-title":"The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone","volume":"160","author":"Samer","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0685","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/15360288.2012.702200","article-title":"Population pharmacokinetics of oxycodone in patients with cancer-related pain","volume":"26","author":"Komatsu","year":"2012","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0690","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/pme.12417","article-title":"Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness","volume":"15","author":"Fudin","year":"2014","journal-title":"Pain Med."},{"issue":"6","key":"10.1016\/j.forsciint.2017.10.022_bib0695","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40265-013-0036-0","article-title":"Cytochrome P450-mediated changes in oxycodone pharmacokinetics\/pharmacodynamics and their clinical implications","volume":"73","author":"Soderberg Lofdal","year":"2013","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0700","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/pme.12380","article-title":"Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness","volume":"15","author":"Linares","year":"2014","journal-title":"Pain Med."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0705","unstructured":"P.X. Iten. FAHREN UNTER DROGEN-ODER MEDIKAMENTENEINFLUSS. FORENSISCHE INTERPRETATION UND BEGUTACHTUNG. 1994."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0710","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0731-7085(99)00200-9","article-title":"Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry","volume":"21","author":"Pizarro","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.forsciint.2017.10.022_bib0715","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-3223(87)90070-9","article-title":"Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects","volume":"22","author":"Angrist","year":"1987","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.forsciint.2017.10.022_bib0720","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/jat\/25.5.400","article-title":"Amphetamines: an update on forensic issues","volume":"25","author":"Logan","year":"2001","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0725","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1970.01750030007002","article-title":"Marihuana, ethanol, and dextroamphetamine: mood and mental function alterations","volume":"23","author":"Hollister","year":"1970","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0730","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4045\/tidsskr.09.34091","article-title":"Kj\u00f8ring under p\u00e5virkning av amfetamin og metamfetamin","volume":"129","author":"Lia","year":"2009","journal-title":"Tidsskr Nor Legeforen."},{"issue":"9","key":"10.1016\/j.forsciint.2017.10.022_bib0735","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0006-3223(95)00497-1","article-title":"Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans","volume":"40","author":"Strakowski","year":"1996","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.forsciint.2017.10.022_bib0740","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0006-3223(98)00168-1","article-title":"Enhanced behavioral response to repeated d-amphetamine and personality traits in humans","volume":"44","author":"Sax","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0745","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.aap.2005.11.005","article-title":"Impairment related to blood amphetamine and\/or methamphetamine concentrations in suspected drugged drivers","volume":"38","author":"Gustavsen","year":"2006","journal-title":"Accid. Anal. Prev."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0750","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00213-004-2061-x","article-title":"The effects of dexamphetamine on simulated driving performance","volume":"179","author":"Silber","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0755","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0925-4927(98)00033-X","article-title":"Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)","volume":"83","author":"Vollenweider","year":"1998","journal-title":"Psychiatry Res. Neuroimag."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0760","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/clpt.1980.52","article-title":"Intranasal and oral cocaine kinetics","volume":"27","author":"Wilkinson","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0765","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pbb.2006.12.015","article-title":"Intranasal cocaine in humans: effects of sex and menstrual cycle","volume":"86","author":"Collins","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0770","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.aap.2011.08.017","article-title":"The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study","volume":"45","author":"Stough","year":"2012","journal-title":"Accid. Anal. Prev."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0775","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-011-2537-4","article-title":"Effects of alcohol (BAC 0.5 per thousand) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety","volume":"222","author":"Veldstra","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0780","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-011-2497-8","article-title":"MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid","volume":"222","author":"Bosker","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0785","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881108099214","article-title":"Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers","volume":"24","author":"Dumont","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0790","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0269881110376687","article-title":"Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers","volume":"25","author":"Dumont","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0795","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-011-2383-4","article-title":"A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"219","author":"Kirkpatrick","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0800","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00213-011-2532-9","article-title":"The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning","volume":"220","author":"Stough","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0805","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d): psychomotor performance and subjective effects","volume":"20","author":"Cami","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.forsciint.2017.10.022_bib0810","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00228-005-0965-y","article-title":"MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers","volume":"61","author":"de la Torre","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.10.022_bib0815","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","article-title":"Pharmacology of MDMA in humans","volume":"914","author":"de la Torre","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.forsciint.2017.10.022_bib0820","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.300.1.236","article-title":"3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics","volume":"300","author":"Hernandez-Lopez","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.forsciint.2017.10.022_bib0825","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA ('ecstasy') in humans","volume":"49","author":"de la Torre","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.022_bib0830","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-006-0434-z","article-title":"MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function","volume":"187","author":"Kuypers","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.forsciint.2017.10.022_bib0835","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1360-0443.2006.01566.x","article-title":"Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75mg and methylphenidate 20mg on actual driving during intoxication and withdrawal","volume":"101","author":"Ramaekers","year":"2006","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.forsciint.2017.10.022_bib0840","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.022_bib0845","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1520\/JFS13935J","article-title":"Methamphetamine and driving impairment","volume":"41","author":"Logan","year":"1996","journal-title":"J. Forensic Sci."},{"issue":"12","key":"10.1016\/j.forsciint.2017.10.022_bib0850","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/0091270007308615","article-title":"Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans","volume":"47","author":"Parasrampuria","year":"2007","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.forsciint.2017.10.022_bib0855","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neubiorev.2003.08.013","article-title":"Serum and brain concentrations of methylphenidate: implications for use and abuse","volume":"27","author":"Swanson","year":"2003","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073817304231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073817304231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:53:58Z","timestamp":1750956838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073817304231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":171,"alternative-id":["S0379073817304231"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2017.10.022","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion factors for assessment of driving impairment after exposure to multiple benzodiazepines\/z-hypnotics or opioids","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}